Antitrust today: Emerging issues affecting the life sciences industry

On Friday, March 12, 2021, the Hogan Lovells Antitrust and Competition team discussed hot antitrust topics in the life sciences industry, including:

  • What life sciences companies should expect with respect to mergers in a new FTC and in the EU.
  • Acquisitions of nascent life sciences competitors.
  • Current conduct issues, such as restrictions in drug development agreements, secondary markets (repair and consumables), and the latest on generic delay theories in patent settlements and beyond.

These quarterly webinars in the Hogan Lovells Antitrust and Competition series addresses a timely antitrust topic explaining the key issues and practical implications for businesses, which will provide valuable insights to both newcomers and experienced antitrust practitioners and in-house counsel alike.

Watch here

CLE
CLE credit is applicable by attending the live webinar. This program offers 1 hour of general CLE credit in California and New York, pending approval of materials. All other attendees may receive a uniform certificate of attendance.

Contact:
Candice Ho
Events Specialist
[email protected]


Previous events in series:

December 10, 2020
What's next for antitrust in 2021

Watch here

 

October 8, 2020
Antitrust and tech: Key issues explained and explored

Watch here


Back To Listing
Loading data